Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.
Felten R, Gallais F, Schleiss C, Chatelus E, Javier RM, Pijnenburg L, Sordet C, Sibilia J, Arnaud L, Fafi-Kremer S, Gottenberg JE. Felten R, et al. Among authors: schleiss c. Lancet Rheumatol. 2022 Jan;4(1):e13-e16. doi: 10.1016/S2665-9913(21)00351-9. Epub 2021 Nov 8. Lancet Rheumatol. 2022. PMID: 34778844 Free PMC article. No abstract available.
Reduced DICER1 Expression Bestows Rheumatoid Arthritis Synoviocytes Proinflammatory Properties and Resistance to Apoptotic Stimuli.
Alsaleh G, Nehmar R, Blüml S, Schleiss C, Ostermann E, Dillenseger JP, Sayeh A, Choquet P, Dembele D, Francois A, Salmon JH, Paul N, Schabbauer G, Bierry G, Meyer A, Gottenberg JE, Haas G, Pfeffer S, Vallat L, Sibilia J, Bahram S, Georgel P. Alsaleh G, et al. Among authors: schleiss c. Arthritis Rheumatol. 2016 Aug;68(8):1839-48. doi: 10.1002/art.39641. Arthritis Rheumatol. 2016. PMID: 26882526
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.
Felten R, Ye T, Schleiss C, Schwikowski B, Sibilia J, Monneaux F, Dumortier H, Jonsson R, Lessard C, Ng F, Takeuchi T, Mariette X, Gottenberg JE. Felten R, et al. Among authors: schleiss c. Rheumatology (Oxford). 2023 Nov 2;62(11):3715-3723. doi: 10.1093/rheumatology/kead096. Rheumatology (Oxford). 2023. PMID: 36869684 Free PMC article.
Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome.
Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A, Devauchelle-Pensec V, Seror R, Larroche C, Perdriger A, Sibilia J, Vallat L, Fornecker LM, Nocturne G, Mariette X, Gottenberg JE. Duret PM, et al. Among authors: schleiss c. Arthritis Rheumatol. 2023 Oct;75(10):1798-1811. doi: 10.1002/art.42550. Epub 2023 Jul 28. Arthritis Rheumatol. 2023. PMID: 37115807
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.
Schleiss C, Ilias W, Tahar O, Güler Y, Miguet L, Mayeur-Rousse C, Mauvieux L, Fornecker LM, Toussaint E, Herbrecht R, Bertrand F, Maumy-Bertrand M, Martin T, Fournel S, Georgel P, Bahram S, Vallat L. Schleiss C, et al. Sci Rep. 2019 Jan 24;9(1):701. doi: 10.1038/s41598-018-36853-8. Sci Rep. 2019. PMID: 30679590 Free PMC article.
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.
Schleiss C, Carapito R, Fornecker LM, Muller L, Paul N, Tahar O, Pichot A, Tavian M, Nicolae A, Miguet L, Mauvieux L, Herbrecht R, Cianferani S, Freund JN, Carapito C, Maumy-Bertrand M, Bahram S, Bertrand F, Vallat L. Schleiss C, et al. Leukemia. 2021 May;35(5):1463-1474. doi: 10.1038/s41375-021-01221-5. Epub 2021 Apr 8. Leukemia. 2021. PMID: 33833385 Free PMC article.